pentobarbital will reduce the extent or result of buprenorphine, extended-acting injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Clients who transfer to buprenorphine extensive-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers need to be monitored to guarantee … Read More